812 NDA

[anonymous]

It means nothing to us. It’s stating that the US Patent office is considering tweaking its rules based on a case and judgement already made regarding OXRs patent being upheld.

I hope you aren’t still here and you are a disgruntled ex employee trying to stir things up. Because if you are currently a part of Supernus, and I honestly want to know the answer to this question, what are you trying to accomplish by posting stuff like that?

No one who actually works here calls TXR “Trok”. So there’s your answer.

 

[anonymous]

It means nothing to us. It’s stating that the US Patent office is considering tweaking its rules based on a case and judgement already made regarding OXRs patent being upheld.

I hope you aren’t still here and you are a disgruntled ex employee trying to stir things up. Because if you are currently a part of Supernus, and I honestly want to know the answer to this question, what are you trying to accomplish by posting stuff like that?

We’re just not sure we can trust management anymore. Just trying to make sure we know what’s going on

 

[anonymous]

This whole Q3 bonus fiasco has just been a distraction from what is ultimately the biggest issue we are currently facing at Supernus and that is the fact that the 812 NDA is obviously delayed at this point. Where is the NDA???

 

[anonymous]

The billion dollar question is whether or not 812 is capable of filling the revenue hole that TXR will experience when the AG goes generic Q1 of next year.

 

[anonymous]

The billion dollar question is whether or not 812 is capable of filling the revenue hole that TXR will experience when the AG goes generic Q1 of next year.

I think the market reaction will be massive. I know Rockville says generic will have no effect on TXR but I think that’s laughable especially after they said CGRP isn’t effecting IR volume and then very next quarter it’s so strong it kills our bonus plan

 

[anonymous]

I think the market reaction will be massive. I know Rockville says generic will have no effect on TXR but I think that’s laughable especially after they said CGRP isn’t effecting IR volume and then very next quarter it’s so strong it kills our bonus plan

If we work harder and boldly present the email survey ‘study’ results we can really move business. Why isn’t any of the email survey data in the leave behinds. That data must be the closest thing corporate home made bread as you can get.

 

[anonymous]

The earnings call tomorrow will likely shed more light on where we are at with 812. Don't miss it!!

Starts at 9am 11/6/19
877-288-1043
ID# 8278897

 

[anonymous]

The earnings call tomorrow will likely shed more light on where we are at with 812. Don't miss it!!

Starts at 9am 11/6/19
877-288-1043
ID# 8278897

Best case scenario you hear “NDA is coming very soon”

 

[anonymous]

Best case scenario you hear “NDA is coming very soon”

No one on that call will say that the “NDA is coming soon”.

 

[anonymous]

As each day passes 812 is looking more and more like Daytrana.

 

[anonymous]

As each day passes 812 is looking more and more like Daytrana.

This has to be a RD who got the axe. Considering Shire stopped selling Daytrana in 2010 no reps here are going to know it. And why would any current RD troll?

 

[anonymous]

This has to be a RD who got the axe. Considering Shire stopped selling Daytrana in 2010 no reps here are going to know it. And why would any current RD troll?

But are they wrong?

 

[anonymous]

I thought 810 was going to be a game changer?

 

[anonymous]

Plot twist: that email was the game changer

 

[anonymous]

Over/Under on Feb 2020 that we get sold/acquired by then?